| Literature DB >> 29206164 |
Giorgio Ivan Russo1, Daniele Campisi2, Marina Di Mauro3, Federica Regis4, Giulio Reale5, Marina Marranzano6, Rosalia Ragusa7, Tatiana Solinas8, Massimo Madonia9, Sebastiano Cimino10, Giuseppe Morgia11.
Abstract
Dietary polyphenols gained the interest of the scientific community due to their wide content in a variety of plant-derived foods and beverages commonly consumed, such as fruits, vegetables, coffee, tea, and cocoa. We aimed to investigate whether there was an association between dietary phenolic acid consumption and prostate cancer (PCa) in South Italy. We conducted a population-based case-control study from January 2015 to December 2016 in a single institution of the municipality of Catania, southern Italy (Registration number: 41/2015). Patients with elevated PSA and/or suspicious PCa underwent transperineal prostate biopsy. A total of 118 histopathological-verified PCa cases were collected and a total of 222 controls were selected from a sample of 2044 individuals. Dietary data were collected by using two food frequency questionnaires and data on the phenolic acids content in foods was obtained from the Phenol-Explorer database (www.phenol-explorer.eu). Association between dietary intake of phenolic acids and PCa was calculated through logistic regression analysis. We found lower levels of caffeic acid (2.28 mg/day vs. 2.76 mg/day; p < 0.05) and ferulic acid (2.80 mg/day vs. 4.04 mg/day; p < 0.01) in PCa when compared to controls. The multivariate logistic regression showed that both caffeic acid (OR = 0.32; p < 0.05) and ferulic acid (OR = 0.30; p < 0.05) were associated with reduced risk of PCa. Higher intake of hydroxybenzoic acids and caffeic acids were associated with lower risk of advanced PCa. High intake of caffeic acid and ferulic acid may be associated with reduced risk of PCa.Entities:
Keywords: Mediterranean diet; diet; phenolic acids; prostate cancer; risk factors
Mesh:
Substances:
Year: 2017 PMID: 29206164 PMCID: PMC6149996 DOI: 10.3390/molecules22122159
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Baseline characteristics of cases and controls.
| Cases ( | Controls ( | ||
|---|---|---|---|
| Age (y), mean (SD) | 69.13 (6.60) | 68.09 (8.18) | 0.19 |
| BMI, mean (SD) | 26.49 (3.34) | 27.49 (3.28) | 0.30 |
| Weight status, | |||
| Normal | 42 (35.6%) | 59 (26.6%) | |
| Overweight | 60 (50.8%) | 127 (57.2%) | |
| Obese | 16 (13.6%) | 36 (16.2%) | |
| Smoking status, | 0.15 | ||
| Non-smoker | 68 (57.6%) | 143 (64.4%) | |
| Current smoker | 50 (42.4%) | 79 (35.6%) | |
| Alcohol intake, | 0.16 | ||
| <12 g/day | 55 (46.6%) | 153 (68.9%) | |
| ≥12 g/day | 63 (53.4%) | 69 (31.1%) | |
| Education, | 0.11 | ||
| Primary/secondary | 96 (81.4%) | 49 (22.1%) | |
| High school/university | 22 (18.6%) | 173 (77.9%) | |
| Physical activity level, | 0.21 | ||
| Low | 38 (32.2%) | 49 (26.2%) | |
| Medium | 64 (54.2%) | 67 (35.8%) | |
| High | 16 (13.6%) | 71 (38.0%) | |
| Family history of prostatic cancer, | 43 (36.44%) | 9 (4.05%) | <0.01 |
SD = standard deviation; BMI = body mass index.
Differences of mean total, subclasses and individual phenolic acids between cases and controls.
| Cases ( | Controls ( | ||
|---|---|---|---|
| Total phenolic acids | 383.41 (522.77) | 400.20 (540.07) | 0.78 |
| Subclasses | |||
| Hydroxybenzoic acids | 218.46 (487.25) | 238.29 (525.82) | 0.73 |
| Hydroxycinammic acid | 164.04 (106.69) | 160.95 (97.57) | 0.78 |
| Hydroxyphenilacetic acid | 0.64 (0.56) | 0.65 (1.07) | 0.34 |
| Individual phenolic acids | |||
| Caffeic acid | 2.76 (1.84) | 2.28 (2.40) | 0.05 |
| Cinnamic acid | 0.48 (0.60) | 0.57 (1.81) | 0.60 |
| Vanillic acid | 0.52 (0.38) | 0.46 (0.59) | 0.34 |
| Ferulic acid | 4.04 (3.35) | 2.80 (2.57) | <0.001 |
SD = standard deviation.
Association between quartiles of total, subclasses and individual phenolic acid intake and prostate cancer.
| Phenolic Acid Quartiles, OR (95% CI) | ||||
|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |
| Total phenolic acids | ||||
| No. of cases | 26 | 35 | 26 | 31 |
| OR (95% CI) a | Ref. | 1.30 (0.68–2.47) | 0.87 (0.44–1.69) | 0.81 (0.41–1.62) |
| OR (95% CI) b | Ref. | 1.21 (0.48–3.00) | 0.65 (0.24–1.69) | 1.02 (0.37–2.78) |
| Hydroxybenzoic acids | ||||
| No. of cases | 31 | 21 | 32 | 34 |
| OR (95% CI) a | Ref. | 0.70 (0.35–1.37) | 0.99 (0.53–1.86) | 0.88 (0.47–1.67) |
| OR (95% CI) b | Ref. | 0.77 (0.30–2.01) | 0.46 (0.18–1.18) | 0.75 (0.29–1.94) |
| Hydroxycinammic acid | ||||
| No. of cases | 28 | 28 | 38 | 24 |
| OR (95% CI) a | Ref. | 0.86 (0.44–1.67) | 1.02 (0.54–1.92) | 0.56 (0.27–1.13) |
| OR (95% CI) b | Ref. | 1.60 (0.64–3.99) | 1.54 (0.60–3.94) | 0.76 (0.27–2.13) |
| Hydroxyphenilacetic acid | ||||
| No. of cases | 17 | 16 | 47 | 38 |
| OR (95% CI) a | Ref. | 0.83 (0.38–1.82) | 2.62 (1.33–5.17) | 1.61 (0.79–3.28) |
| OR (95% CI) b | Ref. | 0.61 (0.24–1.58) | 1.66 (0.71–3.88) | 0.77 (0.29–2.07) |
| Caffeic acid | ||||
| No. of cases | 8 | 14 | 44 | 52 |
| OR (95% CI) a | Ref. | 1.42 (0.71–2.83) | 0.74 (0.39–1.43) | 0.28 (0.13–0.58) |
| OR (95% CI) b | Ref. | 1.86 (0.65–5.29) | 0.79 (0.30–2.08) | 0.32 (0.11–0.87) |
| Cinnamic acid | ||||
| No. of cases | 30 | 29 | 25 | 34 |
| OR (95% CI) a | Ref. | 0.87 (0.45–1.65) | 0.76 (0.39–1.48) | 0.81 (0.42–1.54) |
| OR (95% CI) b | Ref. | 1.29 (0.52–3.20) | 0.69 (0.28–1.73) | 1.06 (0.39–2.83) |
| Vanillic acid | ||||
| No. of cases | 5 | 24 | 53 | 36 |
| OR (95% CI) a | Ref. | 1.84 (0.92–3.67) | 0.99 (0.50–1.94) | 0.53 (0.25–1.11) |
| OR (95% CI) b | Ref. | 0.95 (0.33–2.73) | 0.54 (0.20–1.46) | 0.30 (0.10–0.85) |
| Ferulic acid | ||||
| No. of cases | 19 | 12 | 36 | 51 |
| OR (95% CI) a | Ref. | 1.51 (0.77–2.98) | 0.65 (0.33–1.25) | 0.50 (0.26–0.97) |
| OR (95% CI) b | Ref. | 1.62 (0.60–4.37) | 0.63 (0.25–1.60) | 0.44 (0.17–1.10) |
OR, odds ratio; CI, confidence interval; Ref, Reference; a ORs were adjusted for energy intake (kcal/dayay, continuous); b ORs were adjusted for age (years, continuous), energy intake (kcal/day, continuous), weight status (normal, overweight, obese), smoking status (smokers, non-smokers), alcohol consumption (<12 g/day, ≥12 g/day), physical activity level (low, medium, high), and family history of prostatic cancer.
Association between quartiles of total, subclasses and individual phenolic acid intake and advanced prostate cancer.
| Phenolic Acid Quartiles, OR (95% CI) a | ||||
|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |
| Total phenolic acids | Ref. | 0.75 (0.16–3.55) | 0.68 (0.14–3.21) | 0.34 (0.05–2.22) |
| Subclasses | ||||
| Hydroxybenzoic acids | Ref. | 0.52 (0.09–2.97) | 0.43 (0.50–0.09) | 0.85 (0.86–0.20) |
| Hydroxycinammic acid | Ref. | 0.44 (0.10–1.86) | 0.25 (0.05–1.32) | 0.10 (0.01–1.10) |
| Hydroxyphenilacetic acid | Ref. | 0.45 (0.04–5.18) | 3.40 (0.67–17.22) | 0.71 (0.09–5.66) |
| Individual phenolic acids | ||||
| Caffeic acid | Ref. | 0.62 (0.14–2.74) | 0.31 (0.07–1.33) | 0.01 (0.00–1.00) |
| Cinnamic acid | Ref. | 0.18 (0.02–1.61) | 0.57 (0.13–2.53) | 0.46 (0.10–2.15) |
| Vanillic acid | Ref. | 1.58 (0.35–7.11) | 0.69 (0.14–3.43) | 0.13 (0.01–1.55) |
| Ferulic acid | Ref. | 1.51 (0.32–1.10) | 1.66 (0.97–2.83) | 1.66 (0.97–2.83) |
OR, odds ratio; CI, confidence interval; Ref, Reference; a ORs were adjusted for energy intake (kcal/day, continuous).
Figure 1Distribution of major dietary sources of phenolics in the all cohort.